Related by context. All words. (Click for frequent words.) 65 opiate induced constipation 59 orally disintegrating formulation 58 treat chronic sinusitis 58 phase III isavuconazole 58 candidate deforolimus 58 refractory chronic lymphocytic 58 personalized cellular immunotherapy 57 molecular imaging radiopharmaceutical 57 orally inhaled migraine 57 dutogliptin 57 Somatuline Depot 57 markets HP Acthar 57 thalidomide Thalomid 57 acetonide FA 57 COLAZAL R 56 oral talactoferrin 56 ® lenalidomide 56 DepoDur 56 HCl capsules 56 LEVADEX ™ 56 oxypurinol 56 opioid induced constipation OIC 56 novel therapeutic antibodies 56 oral anti arrhythmic 56 PI3K/Akt pathway inhibitor 56 Azmacort R 56 Gemzar gemcitabine 56 proprietary radiolabeled monoclonal 55 candidate ridaforolimus 55 acyclovir Lauriad R 55 denileukin diftitox 55 adalimumab Humira 55 Panzem R 55 Zavesca r 55 constipation OIC 55 opioid tolerant adult 55 generation purine nucleoside 55 antibody MAb 55 Solorel ® 55 intranasal formulation 55 Tibotec Therapeutics division 55 R sorafenib tablets 55 Trimesta 55 oxazolidinone 55 commercialize deforolimus 55 dual reuptake inhibitor 55 aromatase inhibitor AI 55 Vitrasert R 55 Annamycin 55 rhIGF-I/rhIGFBP-3 55 drug Treanda 55 Ception Therapeutics 55 investigational mTOR inhibitor 55 PHX# 55 Temodar ® 55 RECOTHROM ® 55 cognitive impairment associated 55 Provectus Pharmaceuticals specializes 55 Clolar ® 55 product AMD# 55 telomerase therapeutic 55 dextofisopam 55 investigational antiplatelet agent 54 TELINTRA R 54 candidate TNFerade biologic 54 thetreatment 54 Humira adalimumab 54 VBLOC TM vagal blocking 54 candidate epratuzumab 54 Genasense ® 54 receiving opioid analgesics 54 Triapine 54 oral beclomethasone dipropionate 54 forodesine 54 Canvaxin TM 54 IV Busulfex 54 Degarelix 54 SPL# Gel vaginal microbicide 54 tizanidine hydrochloride short 54 LymphoStat B belimumab 54 including eniluracil ADH 54 DepoCyt 54 vapreotide acetate 54 Equetro 54 Initiates Clinical Trial 54 VBLOC vagal blocking 54 mGluR5 PAM 54 Zolpimist ™ 54 apomorphine hydrochloride 54 generation radiolabeled antibody 54 LymphoStat B TM 54 novel oral anticoagulant 54 alicaforsen 54 NeutroSpec TM 54 Argatroban 54 Proquin XR 54 Intravitreal 54 orally inhaled 54 OvaRex ® MAb 54 Oasmia 54 NeuroSTAT ® 54 acute mania 54 Initiate Clinical Trial 54 gepirone ER 54 drug belatacept 54 proprietary intranasal insulin 54 Alequel 54 non nucleoside inhibitor 54 Deferiprone 54 Gonal f R 54 medically refractory epilepsy 54 dermatology biopharmaceutical company 54 drugs FUSILEV 54 Dementia Related Psychosis 54 LEVADEX TM 54 antihormonal 54 Arimidex anastrozole 54 vasomotor symptoms associated 54 oropharyngeal candidiasis OPC 54 ALN PCS 54 immunotherapeutic agent 54 targeted radiotherapeutic 54 Valtropin 54 mesylate tablets approved 54 Cx# [002] 54 candidates Azedra TM 54 MAGE A3 ASCI 54 vinorelbine tartrate 54 apricitabine ATC 54 lexidronam injection 54 Mipomersen 54 YONDELIS 54 Personalized Immunotherapy 54 Myocet 54 Stanate R 53 SUPPRELIN R LA 53 aerosolized AAT 53 mecasermin 53 alpha1 antitrypsin deficiency 53 Cleviprex TM clevidipine 53 TBC# 53 refractory Hodgkin 53 alemtuzumab Campath 53 NASDAQ SCRX 53 Cytarabine 53 Heterozygous Familial Hypercholesterolemia 53 Tramiprosate ALZHEMED TM 53 investigational pharmacologically unique 53 small molecule thrombopoietin 53 INSPIRE Trial Phase III 53 Familial Adenomatous Polyposis FAP 53 stage chemoresistant ovarian 53 syndrome overactive bladder 53 treat secondary hyperparathyroidism 53 pregabalin Lyrica 53 CRLX# 53 Diabetic Retinopathy DR 53 commercialize elagolix 53 SILENOR TM doxepin HCl 53 psychiatric disorders ATI 53 Zemplar Capsules 53 drug GAP #B# 53 GW# [003] 53 progressive metastatic prostate 53 vinca alkaloid 53 ficlatuzumab 53 TNFerade ™ 53 ZANAFLEX CAPSULES ® tizanidine 53 ORADUR ® 53 interferon gamma 1b 53 Cerimon 53 NU# direct 53 milnacipran HCl 53 PEGylated interferon 53 dasatinib Sprycel 53 PDX pralatrexate 53 Omnitarg 53 evaluating picoplatin 53 Matrix Phase 2b 53 Syndax Pharmaceuticals Inc. 53 Ropinirole 53 DURIN TM 53 nonhuman primate model 53 delivers fluocinolone acetonide FA 53 2 methoxyestradiol 53 BCR ABL inhibitor 53 compound INCB# 53 ALTROPANE R 53 dexanabinol 53 EECP ® therapy 53 nephropathic cystinosis 53 investigational atypical antipsychotic 53 mitoxantrone plus 53 KNS # 53 Pyridorin 53 SANVAR 53 Enbrel rheumatoid arthritis 53 Panzem ® 53 refractory cutaneous T 53 MabThera Rituxan 53 thiazolides 53 Zenapax 53 HYVISC R 53 ADAGEN 53 Chronic Lymphocytic Leukemia CLL 53 Remicade infliximab 53 Plaquenil 53 Sylvie Gregoire President 53 Evoltra ® 53 essential thrombocythemia ET 53 Zenvia ™ 53 midstage clinical 53 5 fluorouracil leucovorin 53 Beyond Advair 53 oral nucleoside analogue 53 PrevOnco ™ 53 TRACON Pharmaceuticals Inc. 53 PROVENGE ® 53 refractory gout 53 candidate SUVN 53 Peginterferon alfa 2b 53 Pancreas Cancer Vaccine 53 Cloretazine ® 53 GVAX ® 53 VIBEX MTX 53 OvaRex 53 Xeloda ® 53 Ecallantide 53 Nutra Pharma wholly owned 52 oral ghrelin agonist 52 treat opioid induced 52 Nanobody R 52 anthracyclines taxanes 52 oral ridaforolimus 52 Panzem R NCD 52 Campath alemtuzumab 52 relapsed leukemia 52 ChronVac C R 52 humanised monoclonal antibody 52 Abiraterone acetate 52 SinuNase TM 52 Inhaled nitric oxide 52 Rhucin ® recombinant 52 PEGylated Fab fragment 52 Liprotamase 52 SYN# 52 SinuNase ™ 52 myelodysplastic myeloproliferative diseases 52 Gel repository corticotropin injection 52 LHRH receptor positive 52 Onalta TM 52 topically applied SEPA 52 TRACON Pharmaceuticals 52 CYT# potent vascular disrupting 52 external counterpulsation systems 52 Saquinavir 52 synthetic peptide containing 52 Modrenal R 52 Aryplase 52 TOCOSOL Camptothecin 52 bone marrow reticulin deposition 52 SPRYCEL ® 52 immunomodulatory therapy 52 developing Bicifadine serotonin 52 antimetabolite 52 candidate CRLX# 52 Zybrestat 52 Shows Statistically Significant 52 leading oral taxane 52 SNS# T 52 Cancidas 52 drug ISA# 52 CTAP# Capsules 52 Troxatyl 52 GERD migraine headaches 52 quetiapine Seroquel 52 regorafenib 52 BioSante Pharmaceuticals Announces 52 NASH Huntington 52 doxepin HCl 52 schizophrenia CIAS 52 Preotact 52 Vitamin D analogue 52 antibiotic candidate Ramoplanin 52 Tibotec BVBA 52 IV APAP 52 Morquio 52 antirheumatic 52 HDL Selective Delipidation 52 Familial Adenomatous Polyposis 52 Nexavar sorafenib 52 Hodgkin lymphoma HL 52 cediranib 52 vaccine GMK 52 targeted antifolate 52 Alimta pemetrexed 52 Acting Injection 52 refractory indolent non 52 blood clot dissolver 52 selective angiogenic kinase inhibitor 52 annuloplasty product 52 Velcade bortezomib 52 oral immunomodulatory 52 injectable formulations 52 neuropathic pain spasticity 52 anti inflammatory NSAID 52 Risperdal risperidone 52 Troxatyl TM 52 Begins Dosing 52 dual orexin receptor 52 AFREZZA ® 52 Glassia 52 hereditary emphysema 52 Tectin TM 52 hyaluronidase enzyme 52 MuGard TM 52 metastatic sarcoma 52 Fludarabine 52 Gleevec imatinib mesylate 52 Ceflatonin R 52 Prism Pharmaceuticals 52 OMAPRO ™ 52 Zemiva TM 52 oncologic diseases 52 Muckle Wells 52 NASDAQ OMER 52 IMiDs ® 52 VANTAS ® 52 MyVax R 52 demonstrated antitumor activity 52 DEB# 52 Simponi golimumab 52 candidate Zenvia 52 inhaled AAT 52 Combivir Kivexa 52 intravenous methylnaltrexone 52 ZEVALIN ® 52 immunological diseases 52 LUNESTA TM 52 ORENCIA R 52 Completes Patient Enrollment 52 metastatic colorectal carcinoma 52 Tovaxin ® 52 OMP #R# 52 immunologic diseases 52 Migranal 52 FOR FURTHER INFORMATION ABOUT 52 Perforomist ™ Inhalation Solution 52 Laevo 52 unresectable locally advanced 52 Cellcept 52 RELOVAIR ™ 52 Bayer HealthCare Onyx Pharmaceuticals 52 humanized therapeutic 52 anti PlGF 52 overactive bladder VANTAS R 52 MOVIPREP R 52 IAGX 52 HP Acthar R 52 adenosine A2A 52 TRAIL receptor antibodies 52 docetaxel Taxotere ® 52 Crofelemer budesonide foam 52 lenalidomide Revlimid 52 CINQUIL 52 GRN# 52 lucinactant 52 HyperAcute 52 class anticancer quinolone 52 undergoing hematopoietic stem 52 QVAR 52 sapacitabine CYC# 52 Sphingomab TM 52 pegylated interferon lambda 52 alpha1 antitrypsin AAT deficiency 52 Sustiva efavirenz 52 DELATESTRYL R 52 neurology immunology 52 GRNVAC1 52 management biostatistical analysis 52 stage IIIb IV 52 Dermylex TM 51 Spiegelmer ® 51 beta 1a 51 Hormone Refractory Prostate Cancer 51 Frozen Shoulder Syndrome 51 TRANSDUR ® 51 Thalomid ® 51 rasagiline tablets 51 adefovir dipivoxil 51 ELADUR ™ 51 Achieves Primary Endpoint 51 BiovaxID ® 51 mGluR4 PAM 51 Selective Electrochemical Tumor Ablation 51 oral Hsp# inhibitor 51 PPAR gamma agonist 51 LUNESTA ® 51 intranasal insulin product 51 selective estrogen receptor modulator 51 Orqis Medical 51 MELAS 51 IAP inhibitors 51 Gonal F 51 AVASTIN 51 Enzyme Replacement Therapy 51 IMiDs ® compound 51 Vantas 51 Riluzole 51 investigational integrase inhibitor 51 neovascular diseases 51 aflibercept VEGF Trap 51 VNS Therapy TM 51 commercializes oncology 51 commercializing therapeutic 51 CRMD# 51 TRIOLEX HE# APOPTONE HE# 51 metastatic pancreatic 51 baminercept 51 PORxin TM platforms 51 acne impetigo 51 Neugene 51 Zytiga 51 nilotinib Tasigna ® 51 OSI Tarceva 51 Nipent R 51 Cloretazine 51 Luveris R Ovidrel R 51 sorafenib tablets 51 Onco TCS 51 adenosine injection 51 acadesine 51 R Saizen R 51 chemotherapy cisplatin 51 albiglutide 51 Zemplar 51 FS Antihemophilic Factor Recombinant 51 nalbuphine ER 51 Pulmonary Arterial Hypertension PAH 51 BRILINTA 51 EVIZON ™ 51 Fludara ® 51 cell carcinoma RCC 51 receptor tyrosine kinase inhibitor 51 Investigational Treatment 51 BUPHENYL R 51 aldehyde dehydrogenase ALDH2 deficiency 51 nilotinib Tasigna 51 donepezil rivastigmine 51 Betaferon Betaseron 51 immunotherapeutic vaccine 51 rheumatoid arthritis inflammatory bowel 51 Compellis 51 Revlimid lenalidomide 51 alfa 2a 51 Bayer Nexavar 51 Associated Adipose Redistribution 51 miconazole Lauriad ® 51 Zorbtive TM 51 RhuDex ® 51 Solazed 51 ELACYT 51 Adjunctive 51 Iluvien TM 51 metastatic hormone refractory 51 incyclinide 51 intravenous RSD# 51 Aflibercept 51 ergot derivatives 51 methylnaltrexone bromide 51 Entocort 51 pafuramidine maleate 51 gamma secretase inhibitor 51 Zeldox 51 XOPENEX Inhalation Solution 51 THALOMID R 51 mertansine 51 5 HT3 antagonist 51 Ixempra 51 Vitrasert ® 51 candidate Zelrix 51 previously untreated follicular 51 induced macular edema 51 BYETTA ® 51 BLP# 51 M# rationally 51 AMEX KAL 51 PF # [002] 51 mild vasodilator 51 davunetide intranasal AL 51 Receives Orphan Drug Designation 51 Iluvien ® 51 relapsing remitting MS RRMS 51 topical gel formulation 51 smoldering multiple myeloma 51 Onalta 51 STRIANT ® testosterone buccal 51 allosteric modulator PAM 51 ZACTIMA 51 integrin inhibitor 51 etanercept Enbrel 51 dasatinib Sprycel ® 51 Solazed TM 51 antiinfective 51 Certolizumab pegol 51 brand eszopiclone 51 BENLYSTA ® 51 occlusion PAO 51 relapsed MM 51 investigational oral hepatitis C 51 Syndrome LEMS 51 Arzerra ofatumumab 51 ORADUR TM 51 Phase IIb clinical trials 51 EVIZON TM 51 Dosa suffers 51 Frova ® 51 candidate ATHX 51 Initiates Enrollment 51 Carbidopa 51 Tibotec Pharmaceuticals Ltd. 51 rheumatoid arthritis thrombocytopenia 51 topical alprostadil 51 CEDAX ® 51 nephropathic cystinosis cystinosis 51 Ostabolin C TM 51 clevidipine 51 Initiates Phase 2b 51 HepeX B TM 51 faropenem medoxomil 51 Latuda 51 subcutaneous methylnaltrexone 51 MoxDuo IV 51 Ampakine compounds 51 Martin Nicklasson CEO 51 MyVax ® 51 candidate NGX 51 use transdermal sumatriptan 51 oncolytic virus therapies 51 humanized monoclonal 51 treat hyperproliferative disorders 51 POSIDUR TM ELADUR TM 51 REMOXY ® 51 Medivation Inc 51 NYSE Amex PBTH 51 fesoterodine 51 AcelRx Pharmaceuticals 51 Initiates Phase II 51 Xeloda capecitabine 51 Vion Pharmaceuticals Inc. 51 pigmentary disorders 51 P#X# antagonist 51 RANK Ligand inhibitor 51 Retisert ® 51 retinal vein occlusion induced 51 anticoagulant reversing agent 51 Simulect 51 Nasdaq ONXX 51 Rilutek 51 bortezomib Velcade 51 RH1 51 midstage clinical trials 51 Sufentanil 51 inhalation powder 51 androgen receptor antagonist 51 Triapine R 51 delta opioid receptor 51 CIP TRAMADOL ER 51 AGILECT R 51 interstitial cystitis IC 51 vitreoretinal disorders 51 Unigene nasal calcitonin 51 EnteroMedics proprietary neuroblocking technology 51 OncoVex 51 Bioral Amphotericin B 51 investigational protease inhibitor 51 MIRAPEX ER 51 class PDE5 inhibitor 51 corticotropin injection 51 Phase Ib study 51 Valproic acid 51 treating chronic myeloid 51 Pegloticase 51 thrombin inhibiting aptamer 51 Presents Positive Preclinical 51 Onalta ™ 51 Bacterin develops manufactures 51 IIa clinical trials 51 Proxinium TM 51 Androxal TM 51 sirtuin inhibitor program 51 trastuzumab Herceptin R 51 overactive bladder syndrome 51 ® eculizumab 51 CTAP# 51 Gelclair R 51 norepinephrine reuptake inhibitor 51 diabetes irritable bowel 51 Phase #b/#a clinical 51 DCVax ® Brain 51 Inc. OTCBB APNS 51 telomerase inhibitor drug 51 lead molecular radiotherapeutic 51 dermatology therapies 51 Reata Pharmaceuticals 51 cancer neuroendocrine tumor 51 Amrubicin 51 JAK2 inhibitor 51 HP Acthar Gel repository 50 dimebon latrepirdine 50 post operative ileus 50 Mitoxantrone 50 PrevOnco 50 IMiD 50 Marqibo TM 50 microtubule inhibitor 50 Prandin 50 buccal spray 50 drug figitumumab 50 3 registrational trial 50 alkylating agent 50 nasal calcitonin product 50 temozolomide Temodar 50 orBec R oral beclomethasone 50 Silenor ® 50 Targretin capsules 50 emulsion formulations 50 Nasdaq SGEN 50 investigational biologic 50 equine osteoarthritis 50 FUSILEV ® 50 lintuzumab SGN 50 R loxapine 50 Ceflatonin 50 ospemifene 50 Abrupt discontinuation 50 Zenpep 50 Zarnestra 50 ankylosing spondylitis psoriatic arthritis 50 AMPAKINE compound 50 EGFr expressing metastatic colorectal 50 rufinamide 50 reduce serum phosphate 50 refractory metastatic 50 Squalamine 50 relapsing multiple sclerosis 50 ONTAK 50 Daxas roflumilast 50 Quinamed 50 stage antibody MT# 50 relapsed mantle 50 therapeutic monoclonal antibody 50 CDP# 50 MabThera rituximab 50 liposomal delivery 50 antibiotic Tygacil 50 Genentech Rituxan 50 Navelbine ® 50 inhaled formulations 50 severe hypercholesterolemia 50 AVINZA ® 50 Empatic ™ 50 TOCOSOL R 50 OTCBB NPHC biotechnology 50 CCR5 mAb 50 Investigational Oral 50 Brovana 50 Carbamazepine 50 Hedgehog Pathway Inhibitor 50 efaproxiral 50 somatostatin analogue 50 nebulised 50 Desvenlafaxine 50 either acutely decompensated 50 Milnacipran 50 Brinavess 50 FDA APPROVES 50 galantamine 50 NAVISTAR R 50 patients coinfected 50 neurotherapy 50 trastuzumab DM1 T DM1 50 erlotinib Tarceva ® 50 Zilver PTX Drug Eluting 50 highly selective adenosine 50 Dual Opioid TM 50 Amgen Neulasta ® 50 Canvaxin 50 TNFerade TM 50 Receives Approvable Letter 50 DELATESTRYL 50 AMRIX 50 Daclizumab 50 punctal plug delivery 50 urethral bulking agent 50 chemotherapy hormonal therapy 50 topical gel containing 50 evaluating T DM1 50 candidate EFAPROXYN TM 50 Sudhir Agrawal D.Phil 50 LIALDA TM 50 DermTech International 50 oral prodrug 50 peripherally acting 50 approved incretin mimetic 50 Mycophenolate Mofetil 50 Clonicel 50 R lenalidomide 50 Sonatherm 50 cromolyn sodium 50 atypical antipsychotic medication 50 Combunox 50 INTEGRILIN R eptifibatide Injection 50 HepaGam B TM 50 Kuvan R 50 ALN VSP Phase 50 OMNARIS HFA 50 REMINYL ® 50 Smac mimetics 50 Generx TM 50 EOquin TM 50 monoclonal antibody MAb 50 ATG Fresenius S 50 selective modulator 50 inhaled liposomal ciprofloxacin 50 NYSE Amex AEN 50 zileuton tablets 50 Evoltra TM 50 BrachySil TM 50 investigational immunotherapy 50 intravenous acetaminophen 50 FIRMAGON R 50 immunomodulatory agents 50 Orencia abatacept 50 BCR ABL inhibitors 50 immuno inflammatory diseases 50 IMiDs 50 radiation sensitizer 50 Capesaris 50 Inc. Nasdaq ALNY 50 Pruvel TM 50 opioid induced constipation 50 Gonal f ® 50 asthma allergic rhinitis 50 sterile lidocaine patch 50 indolent follicular non 50 pharmacologic therapies 50 selective phosphodiesterase 50 Amigal TM 50 commercialize Aganocides 50 novel immunotherapies 50 HCl Tablets 50 HuMax TAC 50 Ceragenix 50 injectable collagenase 50 Friedreich 50 Tech DVAX 50 visilizumab 50 recurrent herpes labialis 50 imaging radiopharmaceuticals 50 oral proteasome inhibitor 50 itraconazole Sporanox 50 Azedra TM 50 OTC BB PVCT http:/www.pvct.com 50 ciprofloxacin hydrochloride 50 FACTIVE R gemifloxacin 50 ® natalizumab 50 DP VPA 50 Nabi HB Intravenous 50 KRN# 50 oxaliplatin Eloxatin 50 Salmedix 50 oral PTH 50 Campath ® 50 Copegus ribavirin 50 CIMZIA r 50 Alexza Staccato 50 Evamist TM 50 Vidaza azacitidine 50 kidney urologic 50 OncoGel 50 oral taxane 50 relapsed acute lymphoblastic 50 PDE4 inhibitor 50 Xyfid TM 50 LPLD 50 recurrent glioblastoma multiforme 50 prophylactic preventive 50 subcutaneous implant 50 iloprost Inhalation Solution 50 Proleukin 50 LAS# [002] 50 refractory myeloma 50 human IgG1 monoclonal 50 depressive episodes associated 50 genetics immunology 50 Etravirine 50 metastatic gastric 50 immuno therapeutic 50 cangrelor 50 equivocal appendicitis 50 Bosutinib 50 Angiotensin Therapeutic Vaccine 50 trastuzumab DM1 50 R brand eszopiclone 50 Egrifta 50 Vancocin ® 50 isoform selective 50 DiabeCell 50 product Fentanyl TAIFUN 50 PNP inhibitor 50 histone deacetylase HDAC inhibitor 50 hypertension osteoarthritis 50 agonistic human 50 vaginal candidiasis 50 SPP# aliskiren 50 metastatic bladder 50 anti CD3 monoclonal 50 Nanotherapeutics 50 Antisoma Plc 50 tezampanel NGX# 50 Albugon 50 Roche Chugai 50 ABILIFY ® 50 Calixa 50 Temsirolimus 50 selective immunoproteasome inhibitor 50 FUSILEV enhances 50 Pseudomonas aeruginosa P. aeruginosa 50 forodesine hydrochloride 50 Xenografts 50 rivastigmine Exelon 50 product Visicol R 50 inflammatory autoimmune diseases 50 Zaleplon 50 EVIZON TM squalamine lactate 50 BARACLUDE R 50 Unit Dose Budesonide 50 EOS NASDAQ MELA 50 Rituxan rituximab 50 medically refractory 50 TRIST study 50 plus prednisone prednisolone 50 MAb therapy 50 R#/MEM 50 psoriasis rheumatoid arthritis 50 endocrine therapies 50 levodopa induced 50 Frova R 50 ZOLINZA 50 Anidulafungin 50 delivery polymer matrix 50 Bevacizumab Avastin 50 mGluR2 positive 50 NeoVisc ® 50 ® erlotinib 50 indications Dupuytren 50 Bellicum 50 Omacetaxine 50 gastrin analogue TT 50 STELARA ® 50 acquired pneumonia HAP 50 Inhalation Solution 50 Spiriva Handihaler 50 Naive Patients 50 allogeneic cell 50 topically delivered 50 nasal corticosteroids 50 GENASIS 50 Imuran 50 markets COLAZAL 50 VNP#M 50 GAMMAGARD 50 initiate Phase 2b 50 HQK 50 related CMV Retinitis 50 antisense inhibitors 50 Abilify aripiprazole 50 allogeneic hematopoietic stem cell 50 basiliximab 50 Allegra fexofenadine 50 Broncus Technologies 50 Sprycel dasatinib 50 Mucinex ® 50 Factor VIIa 50 tumor vascular disrupting 50 candidates Dyloject TM 50 ATL# [002] 50 Adlea TM 50 metastatic colorectal 50 Mesafem 50 cytomegalovirus retinitis 50 Atrigel 50 demethylating agent 50 Zelapar 50 Nebulized Formoterol 50 investigational oral antiplatelet 50 immunotherapeutic vaccines 50 mucositis ProLindac ™ 50 Asmanex 50 blood clot dissolving 50 systemic invasive fungal 50 epoetin alpha 50 oral salmon calcitonin 50 Corixa Corporation 50 Cloretazine R VNP#M 50 ZyStor Therapeutics Inc. 50 Vicinium TM 50 nasally administered 50 CIMZIA r certolizumab pegol 50 Chipscreen 50 gastrointestinal malignancies 50 pharmacogenomic translational research 50 CARBATROL 50 www.antigenexpress.com 50 ketoprofen patch 50 VANTAS R 50 Lixivaptan 50 PNT# 50 CREON 50 Myelodysplastic Syndrome MDS 50 BEMA Buprenorphine 50 hormone LHRH antagonist 50 inhaled bronchodilators 50 Savella ® 50 Fluconazole 50 EFFEXOR XR 50 OVARIAN 50 Zyprexa olanzapine 50 5 lipoxygenase inhibitor 50 OvaRex R 50 intravenous formulations 50 non splenectomized 50 Amgen Neulasta R 50 arsenic trioxide injection 50 SNT MC# 50 toenail onychomycosis 49 Adenoscan R 49 Thrombin topical Recombinant 49 Soliris eculizumab 49 Meritage Pharma 49 pharmacokinetic PK study 49 PEGylated anti 49 Proxinium 49 Difimicin 49 de novo kidney transplant 49 Virulizin 49 LEUKINE 49 Therapeutic Competitors Companies 49 HCV protease inhibitors 49 injectable biologic 49 orally administered inhibitor 49 R bendamustine hydrochloride 49 duloxetine hydrochloride 49 ThermoDox R 49 Nexavar ® 49 Verus Pharmaceuticals 49 bone marrow malignancy 49 Stage IIIB IV 49 hematological cancers notably 49 DepoDur TM 49 EC Cysteamine 49 taxane chemotherapy administered 49 VEGFR2 inhibitor 49 lipoglycopeptide 49 small molecule chemotherapeutic 49 EnzymeRx 49 cytopenias due 49 targeted anticancer therapies 49 single injection viscosupplement 49 treat refractory angina 49 oxymorphone ER 49 octreotide implant 49 investigational antibiotic 49 intravitreal insert 49 platform HDL Mimetic 49 Announces Poster Presentations 49 leukemia AML 49 anastrozole Arimidex 49 Inc. OTCBB SPRX 49 liposomal formulation 49 sedative pentobarbital sodium 49 Diabetic Macular Edema DME 49 Cimzia certolizumab pegol 49 secondary amenorrhea 49 metastatic malignant 49 INxin TM 49 equine osteoarthritis marketed 49 Alnara Pharmaceuticals Inc. 49 methylnaltrexone 49 primary dysmenorrhea 49 risedronate sodium tablets 49 Aricept donepezil 49 imipramine Tofranil 49 trastuzumab Herceptin ® 49 tablet purgative preparation 49 HuCAL antibodies 49 basal insulin analogue 49 Tracleer R